Isentress Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Raltegravir/Calcium Study
Condition:   Calcium Supplementation in HIV Patients Using Raltegravir Intervention:   Combination Product: Calcium supplementation concurrent to HIV treatment with Raltegravir Sponsor:   Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

Raltegravir/Calcium PK Study
Condition:   Calcium Supplementation in HIV Patients Using Raltegravir Intervention:   Combination Product: Calcium supplementation concurrent to HIV treatment with Raltegravir Sponsor:   Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

Combination Antiretroviral Therapy (cART) for PBC
Condition:   Primary Biliary Cholangitis Interventions:   Drug: Emtricitabine (FTC)/Tenofovir Disoproxil (TDF);   Drug: Raltegravir;   Drug: Placebo Oral Capsule [CEBOCAP] Sponsors:   University of Alberta;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials